{"id":9035,"date":"2020-04-28T10:02:13","date_gmt":"2020-04-28T08:02:13","guid":{"rendered":"https:\/\/www.resist-cluster.de\/?page_id=9035"},"modified":"2024-11-07T13:53:27","modified_gmt":"2024-11-07T12:53:27","slug":"prof-dr-kay-gruenewald","status":"publish","type":"page","link":"https:\/\/www.resist-cluster.de\/en\/about-us\/research-team-2\/prof-dr-kay-gruenewald\/","title":{"rendered":"Prof. Dr. Kay Gr\u00fcnewald"},"content":{"rendered":"

<\/div>
<\/div>
<\/div>
<\/div>
<\/div>
<\/div>
<\/div><\/div><\/div>
<\/a><\/span><\/div>

Prof. Dr. Kay Gr\u00fcnewald participates in\u00a0RESIST research projects D1 and D2.<\/p>\n<\/div>

<\/div><\/div><\/div>

\n\n\n
<\/i><\/td>\nMy Research Interest in RESIST<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/h1><\/div>
\n
\n
\n

Our research focus in RESIST is the structural characterisation of stages in the herpesvirus assembly pathway. For this, we use cellular electron cryo microscopy and tomography guided by advanced light microscopy techniques. Studying processes directly inside the infected cell will significantly advance the field as the current understanding of early steps was mainly derived from in vitro<\/i> studies of isolated particles or bulk assays. Capturing metastable assembly intermediates will allow for novel mechanistic insights. Together with other researchers in RESIST the long-term aim is to contribute to new interventions for herpesviral diseases and improving the options for combination therapies that utilize drugs acting at different stages of the viral life cycle.\u00a0<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>

<\/div>
<\/div>
<\/div>
<\/i><\/span>Contact<\/span><\/a><\/div>
<\/div><\/div><\/div><\/div><\/div>
<\/path><\/svg><\/div>
<\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div>
<\/div>
<\/div>
<\/div>
<\/div>
<\/div><\/div><\/div>
<\/div><\/div><\/div>

Prof. Gr\u00fcnewald about his scientific work<\/h1><\/div>